AKBA akebia.com: Rasio Nilai Pasar marang Nilai Buku

Akebia Therapeutics Inc (AKBA) - logo korporat

Akebia Therapeutics (AKBA) relies on an asset-light strategy, outsourcing the production of renal anemia treatments to third-party contractors. This price chart illustrates the asset's dynamics, with a current value of 7.95. Risks are linked to licensing delays for new products and pricing pressure. The company is currently scaling sales and expanding its target markets following recent regulatory approvals.

Akebia Corp (AKBA) - Nilai Pasar marang Nilai Buku saka 04.07.2022 nganti 01.11.2026

Akebia Therapeutics Inc (AKBA) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:
Rega saham Akebia Therapeutics|AKBA - Prakiraan konsensus analis
- data kapitalisasi saham perusahaan:
Nilai pasar Akebia|AKBA - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Akebia Therapeutics|AKBA - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku akebia.com|AKBA - Total Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas Akebia Therapeutics|AKBA - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Akebia|AKBA - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Akebia|AKBA - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Akebia Therapeutics|Likuiditas cepet akebia.com
- indikator bathi lan kelipatan valuasi:
AKBA - Bathi resik
Analisis dhasar perusahaan:Akebia Therapeutics - AKBA
Produk asil prodhuksi Akebia

This ratio compares the market value of the business to its net assets, determining the degree of overvaluation or capital discount relative to book value. For Akebia Therapeutics (AKBA), this balance is critical: regulatory approval of Vafseo mitigates the primary risk, transforming the company's P/BV chart into an indicator of the overvaluation of the potential of its new anemia treatment ecosystem for kidney diseases.

Analisis pesaing

TVTX: Rasio Kapitalisasi Pasar marang Nilai Buku|ardelyx.com (ARDX) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku ProKidney|Cara Therapeutics, Inc. - Kapitalisasi Pasar marang Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku DMAC|UNCY (Unicycive Therapeutics, Inc) - Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku RMTI (Rockwell Medical, Inc.)|Rasio Kapitalisasi Pasar marang Nilai Buku cadrenal.com CVKD|CDT - Rasio Nilai Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku CALT (Calliditas Therapeutics)|Renalytix (RNLX) - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih ZyVersa Therapeutics, Inc.